211 related articles for article (PubMed ID: 28369700)
1. In utero presentation of aggressive systemic mastocytosis in a neonate.
Huang A; Fiadorchanka N; Brar K; Balderacchi JL; Glick SA
Br J Dermatol; 2017 Nov; 177(5):1439-1441. PubMed ID: 28369700
[TBL] [Abstract][Full Text] [Related]
2. c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.
Chaudhary N; Shapiro N; Bhutada A; Rastogi S
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e338-e340. PubMed ID: 30067557
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine.
Angus J; Leach IH; Grant J; Ravenscroft JC
Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456
[TBL] [Abstract][Full Text] [Related]
4. Systemic mastocytosis: A rare cause of non-cirrhotic portal hypertension.
Martins C; Teixeira C; Ribeiro S; Trabulo D; Cardoso C; Mangualde J; Freire R; Gamito É; Alves AL; Cremers I; Alves C; Neves A; Oliveira AP
World J Gastroenterol; 2016 Jul; 22(28):6559-64. PubMed ID: 27605890
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
6. [Mastocytosis: revisited with new cytogenetic data].
Vaes M; Vereecken P; de Wind R; Andry G; Li R; Bron D
Rev Med Brux; 2012; 33(1):12-21. PubMed ID: 22512145
[TBL] [Abstract][Full Text] [Related]
7. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
[TBL] [Abstract][Full Text] [Related]
8. Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
Carter MC; Bai Y; Ruiz-Esteves KN; Scott LM; Cantave D; Bolan H; Eisch R; Sun X; Hahn J; Maric I; Metcalfe DD
Br J Haematol; 2018 Dec; 183(5):775-782. PubMed ID: 30488427
[TBL] [Abstract][Full Text] [Related]
9. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
[TBL] [Abstract][Full Text] [Related]
10. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
11. [Clinical observations in cutan mastocytosis].
Mihalik N; Hidvégi B; Hársing J; Várkonyi J; Csomor J; Kovalszky I; Marschalkó M; Kárpáti S
Orv Hetil; 2013 Sep; 154(37):1469-75. PubMed ID: 24016753
[TBL] [Abstract][Full Text] [Related]
12. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.
Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M
Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
Vergara-de-la-Campa L; Torrado I; Recuero-Pradillo M; Torrelo A; Gironella M; Pardal E; Godoy AC; Matito A; Pérez-Hortet C; Mollejo M; Álvarez-Twöse I
J Dermatol; 2021 May; 48(5):657-660. PubMed ID: 33684229
[TBL] [Abstract][Full Text] [Related]
14. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
Chantorn R; Shwayder T
Pediatr Dermatol; 2012; 29(5):605-9. PubMed ID: 22329485
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
Droogendijk HJ; Kluin-Nelemans HJ; van Doormaal JJ; Oranje AP; van de Loosdrecht AA; van Daele PL
Cancer; 2006 Jul; 107(2):345-51. PubMed ID: 16779792
[TBL] [Abstract][Full Text] [Related]
16. KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.
Broesby-Olsen S; Kristensen T; Vestergaard H; Brixen K; Møller MB; Bindslev-Jensen C;
J Allergy Clin Immunol; 2013 Sep; 132(3):723-728. PubMed ID: 23587333
[TBL] [Abstract][Full Text] [Related]
17. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
18. Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation.
Sandow L; Town A; Heinrich MC
Leuk Res Rep; 2024; 21():100409. PubMed ID: 38273969
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM
Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
